Company Entest BioMedical Inc. Other OTC

US29383T1025

Investment Holding Companies

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Shell Companies

Inactive Instrument

End-of-day quote Other OTC Other stock markets
- ^USD	-

2020	Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2019	CI
2019	Entest Group, Inc. Reports Earnings Results for the Full Year Ended August 31, 2019	CI

Entest Group, Inc., formerly Entest Biomedical, Inc., is engaged in the business combination with an unidentified company. The Company has not entered into any definitive agreement with any party, nor have there been any specific discussions with any potential business combination candidate regarding business opportunities for the Company.

Managers	Title	Age	Since
Peiwen Yu CEO	Chief Executive Officer	54	18-11-27

Members of the board	Title	Age	Since
Peiwen Yu CEO	Chief Executive Officer	54	18-11-27

	Vote	Quantity	Free-Float	Total Float
Stock A	0	667	0	98.54 %
Stock B	0	534	0
Stock C	1	49,171,083	49,171,083 ( 100.00 %)
Stock D	0	728,073	0

Entest Group, Inc.

No. 911 Bao'an Book City Xinqiao Street Central Road

518100, Shenzhen

Financials

Holding Companies

Holding Companies

Investment Holding Companies

Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+173.89%	6.55B
SCREAMING EAGLE ACQUISITION CORP.	+5.57%	1.05B
CHURCHILL CAPITAL CORP VII	+2.29%	983M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+20.36%	786M
ARES ACQUISITION CORPORATION II	+1.72%	664M
ALTC ACQUISITION CORP.	+40.25%	639M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
E7 GROUP	-2.15%	593M

Shell Companies